South Africa remains the epicenter of the HIV pandemic as the largest AIDS epidemic in the world—20 percent of all people living with HIV are in South Africa, and 20 percent of new HIV infections occur there too. The country also faces a high burden of tuberculosis (TB), including multi-drug resistant TB, which amplifies its HIV epidemic. Of particular concern are South Africa’s hyper-epidemics, many in KwaZulu-Natal and Mpumalanga provinces, and the concentration in specific populations like adolescent girls/young women AGYW. Of the estimated 7.2 million South Africans living with HIV, nearly 60 percent are women over the age of 15. HIV prevalence in other key populations—female sex workers, men who have sex with men, transgender women, and people who inject drugs—remains unacceptably high, in some cases double the national prevalence rate of approximately 19 percent.
In some communities of KwaZulu-Natal Province, South Africa, 60 percent of women have HIV. Nearly 4,500 South Africans are newly infected every week; one-third are adolescent girls/young women (AGYW) ages 15-24. These are staggering figures, by any stretch of the imagination. Yet, the HIV epidemic is not being treated like a crisis
The epidemic is exacerbated by its concentration in 15-49-year-olds, those of reproductive and working age who are the backbone of South Africa. Without aggressive action to reduce the rate of new infections in young people, HIV will continue to take a tremendous toll on the country for years and generations to come. Collective action is needed to push beyond the complacency and internal barriers to implement policies and interventions that directly tarAfter the early years of denial, the South African government now finances close to 80 percent of the HIV response, an unparalleled commitment in sub-Saharan Africa, and provides more than 4 million people with life-prolonging anti-retroviral treatment (ART). In 2018, the President of SA called for an increase of 2 million South Africans on ART by December 2020 through increased testing and treatment.
The problem facing South Africa’s HIV response is that treatment scale-up has stalled, and while new infections have gone down by 42 percent, the rate is not fast enough to bend the curve of the epidemic. New infections in young men and women remain alarmingly high (nearly 87 percent of the total) and viral suppression rates, a key to preventing those living with the virus from passing it on, are under 50 percent for those 15-24 years old. With approximately 45 percent of the population under the age of 25, the sheer numbers of those becoming infected and overall prevalence of HIV will stay alarmingly high without a massive decline in the new HIV infection rate.get HIV prevention and treatment for young people
From Center for Strategic and International Studies.
Nutrition and Dietary Status of the HIV patient
• The estimated overall HIV prevalence rate is approximately 13,7% among the South African population. The total number of people living with HIV (PLWHIV) is estimated at approximately 8,2 million in 2021. For adults aged 15–49 years, an estimated 19,5% of the population is HIV positive.
• The high cost of AIDS in the workforce strengthens the argument for investing in HIV prevention programmes and in care for employees. These strategies should help keep knowledgeable, experienced individuals healthier for longer and thus more able to contribute fully to the workforce for as long as possible.
• A nutritional support programme at the work place will ultimately have the benefit of improving and maintaining the health of employees with HIV and keeping such employees productive and contributing to the economy for a longer period.
• In people with HIV/AIDS, nutritional deficits precipitate a cycle that results in a downward spiral of weight loss, mal-absorption, diarrhoea, anorexia, body image disturbances and increased risk for morbidity and mortality.
• The deterioration of the nutritional status of HIV patients has an important effect on the course of disease.
• Research has shown that achieving an adequate nutrient and energy intake for as long as possible, minimizes disease symptoms, enhances quality of life and slows HIV disease progression. HIV positive people have double the protein requirement per day than an uninfected person.
• Oral nutritional supplements have a greater role than dietary advice in the improvement of body weight and energy intake.
• The use of a high-energy, high-protein nutrition supplement should be the primary nutritional treatment for malnourished HIV patients without secondary infections.
• Multiple nutritional abnormalities occur relatively early in the course of HIV infection and therefore early and continued nutritional supplementation may be beneficial in maintaining adequate plasma nutrient levels.
• Certain micronutrients are preferentially lost in HIV infection and AIDS. These are vitamin A, thiamine, vitamin B6, vitamin B12, vitamin C, beta-carotene, iron, selenium, copper and zinc. Vitamin A, zinc and iron supplementation should not exceed the recommended daily allowances as studies have shown that high doses of these micronutrients can promote HIV disease progression.
• A way to improve and maintain the nutritional status of HIV/AIDS patients, especially in a developing country, is to fortify a basic food with micronutrients while ensuring that staple food provides the energy, protein and lipids required for adequate nutrition.
• Soya Life nutritionally enhanced and fortified products help with the nutritional requirements of HIV patients, but also supplies excellent nutrition for healthy persons. The products can be used as meal replacements but also as meal supplements Health benefits of the SPP products include:
1. The products are lactose free. 90-95% of the South African population is lactose intolerant.
2. The protein in the product is of high biological value. The PDCAAS of SP500 is 0.9, the maximum PDCAAS is 1 and equal to egg albumin and casein.
3. The oil in the product is not hydrogenated. 85% of the soy oil is omega 2 and omega 3 fatty acids.Omega-3 fatty acids are the type found in fish and few plant oil sources. They are essential for development of nerve tissues and have many other functions.
4. There are natural phospholipids in the products.
5. The soy oil also contains natural -sitosterols that help to build the immune system.
6. Soya Life soy products contain large amounts of natural plant sterols (Isoflavones) in the products.
7. SPP soy products are whole food products with all the natural wholesomeness with high-energy values.
8. A natural water extraction process, utilizing whole bean technology without any hexane or alcohol extraction, is used to process soybeans.
9. There are no unnecessary preservatives in the products.
10. Soya Life distributes products fortified with additional vitamins and minerals
11. The products are convenience (instantised) products that do not need any cooking or food preparation before eating.
1. AIDS epidemic update December 2000. UNAIDS/WHO
2. HIV/AIDS & STD. Strategic Plan for South Africa 2000-2005
3. UNAIDS Best Practice Collection. Summary Booklet of Best Practice. Issue 2.2000.
4. Thuita FM, Mirie W. Nutrition in the management of acquired immunodeficiency
syndrome. East Afr Med J. 1999;76;(9):507-9
5. Ed. Position of the American Dietetic Association and the Canadian Dietetic
Association: Nutrition intervention in the care of person with human immunodeficiency
virus infection, J Am Diet Assoc 1994;94;(9):1042-5
6. Baldwin C, Parsons T, Logan S. Dietary advice of illness-related malnutrition in adults
(Cochrane Review). In: The Cochrane Library, Issue 2, 2001. Oxford: Update Software.
7. Clader’on E, Ram’irez MA, Arrieta MI, Fern’andez-Caldas E, Russel DW, Lockey FR.
Nutritional disorders in HIV disease. Prog Food Nutri Sci, 1990;14;(4):371-402
8. Timbo BB, Tollefson L. Nutrition: a cofactor in HIV disease. J Am Diet Assoc;
9. Macallan DC. Nutrition and immune function in human immunodeficiency virus
infection. Proc Nutr Soc; 1999;58;(3):743-8
10. Fields-Gardner C, Ayoob KT. Position of the American Dietetic Association and
Dieticians of Canada: Nutrition intervention in the care of persons with human
immunodeficiency virus infection. J Am Diet Assoc; 2000;100;(6):708-717.
11. Casey KM. Malnutrition associated with HIV/AIDS. Part One: Definition and scope,
epidemiology and pathophysiology. AIDS Care 1998;9;(2)
12. Burger B, Schwenk A, Junger H, Olienschlager G, Wessel D, Diehl V, Schrappe M. Oral
supplements in HIV-infected patients with chronic wasting. A prospective trail. Med Klin
13. Guenter P, Muurahainen N, Simons G, Kosok A, Cohan GR, Rubenstein R, Turner JL.
Relationships among nutritional status, disease progression and survival in HIV
infection. J Acquir Immune Defic Syndr 1993;6;(q0):1130-8
14. Dannhauser A, van Staden AM, van der Ryst E, Nel M, Marais M, Erasmus E, Attwood,
EM, Barnard HC, le Roux GD. Nutritional status of HIV-1 seropostitive patients in the
Free State Province of South Africa: anthropmetirc and dietary profile: Eur J Clin
15. Chlebowski RT, Beall G, Grosvenor M, Lillington L, Weintraub N, Ambler C, Richards
EW, Abbruzzese BC, McCamish MA, Cope FO. Long term effect of early nutritional
support with new enterotropic peptide-based formula vs. standard enteral formular in
HIV-infected patients: randomized prospective trail. Nutrition 1993;9/(6):507-12
16. Baum M, Cassetti I, Bonvehi P, Shor-Posner G, Lu Y, Sauberlich H. Inadequate dietary
intake and altered nutrition status in early HIV-1 infection. Nutrition 1994;10;(1);16-20.
17. Vitamin Information Centre, Medical Update 1998;31
18. Delmas-Beauvieux MC, Peuchant E, Coucheron A et al. The enzymatic anti-oxidant
system in blood and glutathione status in human immunodeficiency virus (HIV)-infected
patients: Effects of supplementation with selenium or beta-carotene. American Journal
of Clinical Nutrition 1996;64;(1):101-7.
19. Baum MK, Shor-Posner G, Lai S et al. High risk of HIV-related mortality is associated
with selenium deficiency. J Acquir Immune Defic Syndro Hum Retrovirol
20. Muti RM, Von Overbeck J, Furrer J, Ballmer PE. Thiamin deficiency in HIV-positive
patients: evaluation by erythrocyte transketolase activity and thiamin pyrophosphate
effect. Clin Nutr 1999;18;(6):375-8.